Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05065281
Other study ID # RÖ-786
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date September 16, 2021
Est. completion date June 30, 2024

Study information

Verified date October 2022
Source Region Östergötland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The prevalence of elder abuse has been reported between 10-15% in international studies. Elder abuse may include both physical, emotional, sexual and financial abuse as well as neglect and it occurs at the hand of both professionals and family members, including adult children and intimate partners. Elder abuse has been associated with psychological ill-health, disability, increased hospitalization, emergency department use and admission to nursing facilities. Elder abuse is however often unknown to health care providers. Older adults are hesitant to disclose abuse and health care providers are often reluctant to ask questions. In this study an interactive educational model for health care professionals about elder abuse will be tested. The model consist of theoretical lectures, brief films showing patient encounters, group discussions and forum play, a form of participatory theater. Both group discussions and forum play will be using case scenarios as a cornerstone. The validated questionnaire REAGERA-P will be used for self-reported measures


Description:

Please refer to the uploaded study protocol for a detailed description of the study.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 750
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Employee at one of the clinics participating in the trial - Work tasks involves direct patient contact, at least part time - Participation at the training sessions Exclusion Criteria: - Only administrative work and no direct patient contact - Not participating at the training session

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Education
Training for health care professionals on how to identify and manage cases of elder abuse among their patients

Locations

Country Name City State
Sweden Region Jönköpings län Eksjö
Sweden Region Jönköpings Län Jönköping
Sweden Region Östergötland Linköping
Sweden Region Östergötland Norrköping

Sponsors (5)

Lead Sponsor Collaborator
Region Östergötland Kamprad Family Foundation, Linkoeping University, Linnaeus University, Region Jönköping County

Country where clinical trial is conducted

Sweden, 

References & Publications (2)

Ludvigsson M, Motamedi A, Westerlind B, Swahnberg K, Simmons J. Responding to Elder Abuse in GERiAtric care (REAGERA) educational intervention for healthcare providers: a non-randomised stepped wedge trial. BMJ Open. 2022 May 4;12(5):e060314. doi: 10.1136/bmjopen-2021-060314. — View Citation

Simmons J, Wenemark M, Ludvigsson M. Development and validation of REAGERA-P, a new questionnaire to evaluate health care provider preparedness to identify and manage elder abuse. BMC Health Serv Res. 2021 May 19;21(1):473. doi: 10.1186/s12913-021-06469-2. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Change between baseline and follow up concerning number of elder abuse victims identified at the clinics included in the study, as reported in the medical records Anonymous data from the medical records counting the number of older patients treated at each clinic that have been identified as victims of abuse during the last 6 months Baseline, 6 month follow up, 12 month follow up
Other Change between baseline and follow up concerning adequate follow up, as reported in the questionnaire REAGERA-P Frequency of respondents reporting that identified cases of elder abuse were given adequate follow up Baseline, 6 month follow up, 12 month follow up
Other Change between baseline and follow up concerning self-reported hesitancy for asking questions about elder abuse, as reported in the questionnaire REAGERA-P Frequency of respondents reporting that they have suspected cases of elder abuse but refrained from asking questions Baseline, 6 month follow up, 12 month follow up
Other Degree of changed practice as reported in the questionnaire REAGERA-P Frequency of participants self-reporting that they have changed their working practices as a result of the educational intervention 6 month follow up
Primary Change between baseline and follow up concerning asking questions about abuse, as reported in the questionnaire REAGERA-P Self-report measure of asking older patients about abusive experience. Will be measure both as a dichotomous value (have ever asked questions during the last 6 months) as well as a frequency measure where participants report how often they have asked patients questions about abuse during the last 6 months (on a scale from 0 to 10 or more) Baseline, 6 month follow up, 12 month follow up
Secondary Change between baseline and follow up concerning awareness of elder abuse and sense of responsibility for identifying victims, as reported in the questionnaire REAGERA-P Self-reported perceived lack of awareness of elder abuse as a barrier toward identifying victims.
Self reported sense of responsibility for asking questions about abuse (own responsibility, professions' responsibility, health care services responsibility)
Baseline, Immediate post-intervention (number 2), 6 month follow up, 12 month follow up
Secondary Change between baseline and follow up concerning level of awareness of abuse in contact with patients, as reported in the questionnaire REAGERA-P Patient case ("Vignette") with indicators of abuse and participants self-report if they think they would have asked the patient questions about abuse Baseline, 6 or 12 month follow up (different for different clusters)
Secondary Change between baseline and follow up concerning perceived ability to ask questions about abuse, as reported in REAGERA-P Self-reported self-efficacy for asking questions about elder abuse.
Self-reported cause for concern that asking questions will a) lead to a negative reaction from the patient b) negatively impact the patient-provider relationship
Baseline, Immediate post-intervention, 6 month follow up, 12 month follow up
Secondary Change between baseline and follow up concerning perceived preparedness to manage cases of elder abuse, as reported in REAGERA-P Self-reported self-efficacy for managing cases of elder abuse.
Self-reported cause for concern of not being able to offer the patient a good follow up.
Self-reported collegial support, i.e., knowing which colleague to ask for help if needed when managing cases of elder abuse.
Self-reported knowledge about proper documentation routines
Self-reported knowledge about judicial concerns
Baseline, Immediate post-intervention (number 1and 2), 6 months follow up, 12 months follow up
Secondary Change between baseline and follow up concerning preparedness at the clinic to care for older adults subjected to abuse, as reported in REAGERA-P Self-reported evaluation of:
Routines for managing cases of elder abuse at the clinic
Preparedness at the clinic and in society to care for victims of elder abuse.
Baseline, 6 months follow up, 12 months follow up
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1

External Links